Zynrelef Indication Expanded to Include More Surgical Procedures
Zynrelef is a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine and meloxicam.
Anesthetics
ASA: Spinal Anesthesia Not Superior for Hip Fracture Surgery
Composite outcome of survival and recovery of ambulation at 60 days similar with spinal anesthesia, general anesthesia in older adults
Zynrelef Now Available for Postsurgical Analgesia for Up to 72 Hours
Zynrelef is a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine, an amide local anesthetic, and meloxicam, an NSAID.
Zynrelef Approved to Treat Postoperative Pain for Up to 72 Hours
The needle-free product is intended for single-dose administration only.
Possible Sterility Breach Prompts Recall of Phenylephrine Hydrochloride Injection
A non-integral crimped vial overseal may result in a non-sterile product.
Dexmedetomidine No Better Than Propofol for Adults With Sepsis
For light sedation of mechanically ventilated patients with sepsis, number of days alive without delirium or coma similar between groups
FDA Approves Posimir for Postsurgical Analgesia
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
Byfavo Now Available for Induction, Maintenance of Procedural Sedation
Byfavo, a Schedule IV controlled substance, is a rapid-acting, reversible benzodiazepine.
Neuromuscular Blocker Recalled Due to Label Mix-Up
The recall was initiated after a product complaint revealed that a portion of the lot contained vials mislabeled as Phenylephrine Hydrochloride Injection 100mg/10mL.
New Drugs Approved in 2020
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
